Developer docs
API playgroundTry for free, no card

Search company profiles

ieso

Full company profile

uuid0000avh

Namestring
ieso
Legal namestring
ieso Digital Health Inc.
Websiteurl
iesogroup.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

ieso is a Cambridge-headquartered digital mental health company that has evolved from a direct therapy provider into an AI platform licensor. Its core product, Velora, is a conversational AI platform that delivers evidence-based cognitive behavioral therapy (CBT) support for symptoms of anxiety and depression, built on a proprietary training corpus of more than 750,000 hours of therapy session data encompassing over 1 billion words accumulated across 20+ years of clinical research and service delivery. The platform integrates into partner care pathways via API or white-label web app, embedding AI-generated therapeutic skills into existing clinical workflows with built-in risk detection and human oversight.

The company operates a B2B enterprise go-to-market model, targeting digital health companies and employers seeking to add scalable mental health capabilities to their platforms without adding clinical headcount. Pricing is quote-based on annual subscription terms. ieso monetizes through platform licensing agreements rather than direct-to-consumer therapy delivery, a model crystallized following the August 2025 divestiture of its NHS-focused subsidiary (ieso Digital Health UK) to Sweden's Mindler. Post-divestiture, ieso's parent entity retains its US-incorporated subsidiary (ieso Digital Health Inc., headquartered in Boston) and a research alliance network spanning ten universities plus Roche and NHS Dorset.

ieso reports having 51-100 employees and $78 million in cumulative disclosed funding, with the most recent round a $53 million Series B led by Morningside with participation from Sony Innovation Fund in November 2021. Leadership is anchored by CEO Nigel Pitchford, Executive Chair Dave Icke, Chairman Andy Richards, CFO Michael Black, and Group Chief Science & Strategy Officer Andy Blackwell, with dedicated EVP roles for Clinical, Impact, and Finance & Commercial functions. The company claims 3:1 ROI across populations supported by Velora, citing reductions in ER visits, improved medication adherence, and lower behavioral health episode costs.

Short descriptiontext

ieso is a Cambridge, UK-based digital mental health company that licenses its Velora conversational AI platform to digital health companies and employers via API or white-label deployment, delivering CBT-based anxiety and depression support built on 750,000+ hours of proprietary therapy data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital mental health, AI therapy platform, cognitive behavioral therapy, behavioral health technology, digital therapeutics
Industry1 code
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Offices of Mental Health Practitioners (except Physicians)621330
SIC code1 code
  • Services-Health Services8000
Product category
Digital Mental Health Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Platform Licensing / API Access
TypeSubscription Recurring
Description

ieso licenses its Velora platform technology to digital health companies through API integration or white-label deployment. The model supports digital health companies seeking to embed mental health support into their care pathways.

ieso.ai
2US Market Expansion
TypeSubscription Recurring
Description

Following 2025 expansion of Velora AI platform across the United States, ieso is targeting the large US mental health market to generate revenue through platform licensing agreements with US digital health companies and employers.

businessweekly.co.uk
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise platform licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

ieso.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Velora
Description

Evidence-based AI-powered mental health support program for people with symptoms of anxiety and depression, integrating into clinical workflows via API or white-label web app to deliver personalized mental health support.

ieso.ai
Core offering1 text field

ieso develops and licenses Velora, an AI-powered digital therapeutic platform that delivers evidence-based cognitive behavioral therapy (CBT) support for people experiencing symptoms of anxiety and depression. Velora is distributed via API or white-label web app to digital health companies and employers, embedding CBT-based mental health support directly into existing clinical workflows and care pathways.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 3:1 ROI across supported populations
+4 more records
Product overview1 text field

ieso operates as a mental health technology company offering a single core product platform called Velora. Velora is an AI-powered digital therapeutic program specifically designed for anxiety and depression support. The platform delivers evidence-based CBT skills through conversational AI, integrating seamlessly into digital health companies' existing care pathways via API or white-label web app. Velora represents ieso's complete product portfolio, focused on reducing costs and improving outcomes for digital health companies and employers.

Product and service1 record
1Velora
CategoryDigital Therapeutics / Behavioral Health Software
Description

Velora is an evidence-based AI-powered mental health program that supports people with symptoms of anxiety and depression. It integrates via API or white-label web app into clinical workflows to deliver personalized, clinically validated CBT-based skills, reducing avoidable utilization, improving medication adherence, and increasing engagement among chronic and behavioral health cohorts. It is designed for digital health companies and employers seeking to embed mental health support into their platforms or benefits.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-08-22
Description

Mindler acquired ieso Digital Health UK, the NHS-focused arm of Cambridge-based ieso. The acquisition combines Mindler's pan-European digital therapy platform with ieso's video and text-based CBT services. ieso Digital Health UK retains its UK managing director and operates under the Mindler brand, while ieso's parent company continues independently focusing on AI-powered mental health products.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration partner. ieso collaborates with Roche to study and publish findings that advance the mental health field through evidence-based research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration partner for advancing mental health through academic research and clinical validation studies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Home institution of ieso's origin; ongoing research collaboration for clinical research and evidence development in digital mental health.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner collaborating on studies and publications advancing the digital mental health field.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner contributing to evidence base for AI-powered mental health solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration partner for digital mental health evidence development.

8University of Edinburgh
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner for research and clinical validation in mental health technology.

ieso.ai
9The University of Sheffield
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration partner advancing mental health through academic partnerships.

ieso.ai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner in digital mental health studies and publications.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner contributing to research in mental health technology and evidence development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner providing real-world care delivery context for research and validation of digital mental health solutions.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Woebot Health builds AI-powered conversational mental health tools for anxiety and depression, serving health plans and employers via B2B channels. Directly comparable to ieso's Velora in product category (AI CBT for behavioral health), target buyers (payers/employers), and evidence-based positioning.

TypeDirect peer
Description

Wysa offers an AI-chatbot-based mental health support product sold B2B to employers and health plans. Comparable to Velora as an AI-driven, text-based CBT-style platform for anxiety/depression distributed via enterprise channels.

TypeDirect peer
Description

Limbic is a UK-based AI mental health platform with NHS traction, offering AI triage and self-help tools integrated into IAPT pathways. Closely comparable to ieso in geography (UK roots), NHS heritage, evidence-based AI positioning, and B2B distribution to health systems.

TypeBroad incumbent
Description

Spring Health is a large, well-capitalized mental health benefits platform serving employers, combining provider networks with digital tools. Comparable to ieso as a competing enterprise buyer target for digital mental health spend, though Spring offers a much broader product portfolio beyond AI CBT.

TypeBroad incumbent
Description

Lyra Health is a large employer-focused mental health benefits provider combining live therapy, coaching, and digital self-serve tools. Comparable as an enterprise mental health competitor for the same employer buyer, though its breadth and provider-network model differ from ieso's pure-AI offering.

TypeBroad incumbent
Description

Headspace Health (the combined Headspace/Ginger entity) is a scaled digital mental health platform selling to employers, payers, and consumers. Comparable to ieso as an enterprise digital mental health competitor, with overlapping employer buyers and broader consumer brand reach.

TypeBroad incumbent
Description

Talkspace provides online therapy and psychiatric services to enterprises, health plans, and consumers. Comparable to ieso in serving enterprise mental health buyers and addressing anxiety/depression, though Talkspace is clinician-led rather than AI-first.

TypeEmerging player
Description

Mindler is a Swedish digital therapy provider that acquired ieso Digital Health UK in August 2025. Directly relevant as the acquirer of ieso's legacy NHS arm and a near-clone in digital CBT delivery to health systems across Europe.

TypeDirect peer
Description

Akili Interactive is a prescription digital therapeutic company with FDA-cleared products for cognitive and behavioral health conditions. Comparable to ieso in the digital therapeutics (DTx/SaMD) category for behavioral health, though Akili focuses on ADHD rather than anxiety/depression.

TypeDirect peer
Description

Big Health produces digital therapeutic products (e.g., Sleepio, Daylight) for insomnia and anxiety, distributed via employers and health plans. Comparable to ieso in digital therapeutics category, behavioral health indication (anxiety), and enterprise channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ieso

Digital Mental Health Softwareiesogroup.com

ieso is a Cambridge, UK-based digital mental health company that licenses its Velora conversational AI platform to digital health companies and employers via API or white-label deployment, delivering CBT-based anxiety and depression support built on 750,000+ hours of proprietary therapy data.

What ieso does

ieso is a Cambridge-headquartered digital mental health company that has evolved from a direct therapy provider into an AI platform licensor. Its core product, Velora, is a conversational AI platform that delivers evidence-based cognitive behavioral therapy (CBT) support for symptoms of anxiety and depression, built on a proprietary training corpus of more than 750,000 hours of therapy session data encompassing over 1 billion words accumulated across 20+ years of clinical research and service delivery. The platform integrates into partner care pathways via API or white-label web app, embedding AI-generated therapeutic skills into existing clinical workflows with built-in risk detection and human oversight.

The company operates a B2B enterprise go-to-market model, targeting digital health companies and employers seeking to add scalable mental health capabilities to their platforms without adding clinical headcount. Pricing is quote-based on annual subscription terms. ieso monetizes through platform licensing agreements rather than direct-to-consumer therapy delivery, a model crystallized following the August 2025 divestiture of its NHS-focused subsidiary (ieso Digital Health UK) to Sweden's Mindler. Post-divestiture, ieso's parent entity retains its US-incorporated subsidiary (ieso Digital Health Inc., headquartered in Boston) and a research alliance network spanning ten universities plus Roche and NHS Dorset.

ieso reports having 51-100 employees and $78 million in cumulative disclosed funding, with the most recent round a $53 million Series B led by Morningside with participation from Sony Innovation Fund in November 2021. Leadership is anchored by CEO Nigel Pitchford, Executive Chair Dave Icke, Chairman Andy Richards, CFO Michael Black, and Group Chief Science & Strategy Officer Andy Blackwell, with dedicated EVP roles for Clinical, Impact, and Finance & Commercial functions. The company claims 3:1 ROI across populations supported by Velora, citing reductions in ER visits, improved medication adherence, and lower behavioral health episode costs.

ieso firmographics

Firmographics
Name
ieso
Legal name
ieso Digital Health Inc.
Website
https://iesogroup.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
51–100 employees
Short description
ieso is a Cambridge, UK-based digital mental health company that licenses its Velora conversational AI platform to digital health companies and employers via API or white-label deployment, delivering CBT-based anxiety and depression support built on 750,000+ hours of proprietary therapy data.
Ownership category
akta.pro rank

ieso industry classification

Industry
Product category
Digital Mental Health Software
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Mental Health Practitioners (except Physicians) (621330)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital mental health
  • AI therapy platform
  • Cognitive behavioral therapy
  • Behavioral health technology
  • Digital therapeutics

Where ieso is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

ieso business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Platform Licensing / API Access: ieso licenses its Velora platform technology to digital health companies through API integration or white-label deployment. The model supports digital health companies seeking to embed mental health support into their care pathways.
  2. US Market Expansion: Following 2025 expansion of Velora AI platform across the United States, ieso is targeting the large US mental health market to generate revenue through platform licensing agreements with US digital health companies and employers.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise platform licensing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

ieso product offering

Product offering

Core offering

ieso develops and licenses Velora, an AI-powered digital therapeutic platform that delivers evidence-based cognitive behavioral therapy (CBT) support for people experiencing symptoms of anxiety and depression. Velora is distributed via API or white-label web app to digital health companies and employers, embedding CBT-based mental health support directly into existing clinical workflows and care pathways.

Product overview

ieso operates as a mental health technology company offering a single core product platform called Velora. Velora is an AI-powered digital therapeutic program specifically designed for anxiety and depression support. The platform delivers evidence-based CBT skills through conversational AI, integrating seamlessly into digital health companies' existing care pathways via API or white-label web app. Velora represents ieso's complete product portfolio, focused on reducing costs and improving outcomes for digital health companies and employers.

Differentiator

Problem solved

Functional benefit

Brands

  • Velora: Evidence-based AI-powered mental health support program for people with symptoms of anxiety and depression, integrating into clinical workflows via API or white-label web app to deliver personalized mental health support.

Products and services

  • Velora Velora is an evidence-based AI-powered mental health program that supports people with symptoms of anxiety and depression. It integrates via API or white-label web app into clinical workflows to deliver personalized, clinically validated CBT-based skills, reducing avoidable utilization, improving medication adherence, and increasing engagement among chronic and behavioral health cohorts. It is designed for digital health companies and employers seeking to embed mental health support into their platforms or benefits.

Quantifiable outcome

  • 3:1 ROI across supported populations
  • +4 more outcomes

Companies that use ieso

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

ieso technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature1 record

ieso partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered flagship and core.

  • MindlerflagshipStrategic or Co-development Partner · 22 August 2025Mindler acquired ieso Digital Health UK, the NHS-focused arm of Cambridge-based ieso. The acquisition combines Mindler's pan-European digital therapy platform with ieso's video and text-based CBT services. ieso Digital Health UK retains its UK managing director and operates under the Mindler brand, while ieso's parent company continues independently focusing on AI-powered mental health products.
  • RochecoreStrategic or Co-development PartnerResearch collaboration partner. ieso collaborates with Roche to study and publish findings that advance the mental health field through evidence-based research.
  • University of OxfordcoreStrategic or Co-development PartnerResearch collaboration partner for advancing mental health through academic research and clinical validation studies.
  • University of CambridgecoreStrategic or Co-development PartnerHome institution of ieso's origin; ongoing research collaboration for clinical research and evidence development in digital mental health.
  • King's College LondoncoreStrategic or Co-development PartnerAcademic research partner collaborating on studies and publications advancing the digital mental health field.
  • Imperial College LondoncoreStrategic or Co-development PartnerAcademic research partner contributing to evidence base for AI-powered mental health solutions.
  • The University of ManchestercoreStrategic or Co-development PartnerResearch collaboration partner for digital mental health evidence development.
  • University of EdinburghcoreStrategic or Co-development PartnerAcademic partner for research and clinical validation in mental health technology.
  • The University of SheffieldcoreStrategic or Co-development PartnerResearch collaboration partner advancing mental health through academic partnerships.
  • Queen Mary University of LondoncoreStrategic or Co-development PartnerAcademic research partner in digital mental health studies and publications.
  • Memorial UniversitycoreStrategic or Co-development PartnerAcademic partner contributing to research in mental health technology and evidence development.
  • NHS DorsetcoreStrategic or Co-development PartnerClinical partner providing real-world care delivery context for research and validation of digital mental health solutions.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

ieso competitors and assessment

Company assessment

Direct peers

  • Woebot Health: Woebot Health builds AI-powered conversational mental health tools for anxiety and depression, serving health plans and employers via B2B channels. Directly comparable to ieso's Velora in product category (AI CBT for behavioral health), target buyers (payers/employers), and evidence-based positioning.
  • Wysa: Wysa offers an AI-chatbot-based mental health support product sold B2B to employers and health plans. Comparable to Velora as an AI-driven, text-based CBT-style platform for anxiety/depression distributed via enterprise channels.
  • Limbic: Limbic is a UK-based AI mental health platform with NHS traction, offering AI triage and self-help tools integrated into IAPT pathways. Closely comparable to ieso in geography (UK roots), NHS heritage, evidence-based AI positioning, and B2B distribution to health systems.
  • Akili Interactive: Akili Interactive is a prescription digital therapeutic company with FDA-cleared products for cognitive and behavioral health conditions. Comparable to ieso in the digital therapeutics (DTx/SaMD) category for behavioral health, though Akili focuses on ADHD rather than anxiety/depression.
  • Big Health: Big Health produces digital therapeutic products (e.g., Sleepio, Daylight) for insomnia and anxiety, distributed via employers and health plans. Comparable to ieso in digital therapeutics category, behavioral health indication (anxiety), and enterprise channel.

Broad incumbents

  • Spring Health: Spring Health is a large, well-capitalized mental health benefits platform serving employers, combining provider networks with digital tools. Comparable to ieso as a competing enterprise buyer target for digital mental health spend, though Spring offers a much broader product portfolio beyond AI CBT.
  • Lyra Health: Lyra Health is a large employer-focused mental health benefits provider combining live therapy, coaching, and digital self-serve tools. Comparable as an enterprise mental health competitor for the same employer buyer, though its breadth and provider-network model differ from ieso's pure-AI offering.
  • Headspace Health: Headspace Health (the combined Headspace/Ginger entity) is a scaled digital mental health platform selling to employers, payers, and consumers. Comparable to ieso as an enterprise digital mental health competitor, with overlapping employer buyers and broader consumer brand reach.
  • Talkspace: Talkspace provides online therapy and psychiatric services to enterprises, health plans, and consumers. Comparable to ieso in serving enterprise mental health buyers and addressing anxiety/depression, though Talkspace is clinician-led rather than AI-first.

Emerging players

  • Mindler: Mindler is a Swedish digital therapy provider that acquired ieso Digital Health UK in August 2025. Directly relevant as the acquirer of ieso's legacy NHS arm and a near-clone in digital CBT delivery to health systems across Europe.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

ieso social profiles

Digital presence

ieso financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ieso leadership team

Management profile

Number of profiles

Profiles10 records

ieso funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ieso M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ieso

What does ieso do?

ieso develops and licenses Velora, an AI-powered digital therapeutic platform that delivers evidence-based cognitive behavioral therapy (CBT) support for people experiencing symptoms of anxiety and depression. Velora is distributed via API or white-label web app to digital health companies and employers, embedding CBT-based mental health support directly into existing clinical workflows and care pathways.

Is ieso a public or private company?

ieso is a private company. It is classified as venture growth investor backed and is currently operating.

When was ieso founded?

ieso was founded in 2000. It employs 51 to 100 people.

Where is ieso based?

ieso is headquartered in Cambridge, United Kingdom, in the Europe region.

How does ieso make money?

Two revenue lines are on record. Platform Licensing / API Access are the primary driver. The others are US Market Expansion.

Who are ieso's main competitors?

Direct peers on record are Woebot Health, Wysa, Limbic, Akili Interactive and Big Health. Broad incumbents are Spring Health, Lyra Health, Headspace Health and Talkspace. Mindler is listed as an emerging player.

Does ieso have an API?

Yes. ieso offers an API that integrates into existing care platforms and clinical workflows to deliver Velora's AI-powered mental health support. The API enables digital health companies to embed clinically validated CBT-based skills into their care pathways. White-label web app integration is also available.

What industry is ieso in?

ieso's product category is Digital Mental Health Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 621420 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
JD SupraProcurement Future for Repowered Facilities in OntarioOntario's Independent Electricity System Operator (IESO) announced a new procurement stream for repowered electricity facilities under its Long-Term 2 Request for Proposals, setting a cap of 1 terawatt alongside a separate 3 terawatt target for new-build facilities. The IESO will allow existing facilities with expiring contracts to participate in an interim Medium-Term 3 procurement to bridge operations until they can compete as repowered bids by an expected commercial operation date of 2032. The IESO also plans a less prescriptive regulatory approach for repowered facilities compared to new-build streams, with stakeholder feedback due by March 13, 2026.ArcticstartupSweden’s Mindler acquires ieso Digital Health UK to expand NHS-focused digital therapy servicesSwedish digital therapy provider Mindler has acquired ieso Digital Health UK, the NHS-focused arm of Cambridge-based ieso, consolidating two established players in online mental healthcare under the Mindler brand while maintaining existing NHS contracts and patient services. The transaction creates a market-leading digital mental health platform combining Mindler's pan-European operations with ieso's video and text-based cognitive behavioural therapy services, which have supported over 145,000 NHS patients across England and Scotland. Ieso's parent company will continue operating independently with a focus on AI-powered mental health products, while ieso Digital Health UK will retain its UK managing director and operate under the Mindler brand.BebeezSweden’s Mindler acquires ieso Digital Health UK to Eexpand NHS-focused digital therapy services – BeBeez InternationalSwedish digital therapy provider Mindler has acquired ieso Digital Health UK, the NHS-focused arm of Cambridge-based ieso, consolidating two of the most established players in online mental healthcare. The acquisition brings together Mindler's pan-European platform with ieso's video- and text-based cognitive behavioural therapy services, which have supported over 145,000 NHS patients across England and Scotland. The combined entity will now cover one-third of integrated care systems in England plus a national contract in Scotland, creating a market-leading digital mental health platform.Med-Tech InsightsUK’s ‘most comprehensive’ digital mental health platform to be createdStockholm-based Mindler has acquired Cambridge-based ieso Digital Health UK, a provider of online talking therapies serving over 20 million adults through the NHS. The acquisition creates what the company claims is the UK's most comprehensive digital mental health platform by combining Mindler's pan-European digital therapy platform with ieso's video and typed CBT as well as AI-powered clinical tools, covering contracts with one-third of England's integrated care systems and a national Scottish contract. The deal is part of Mindler's broader strategy to expand its digital mental health services across Europe, building on previous acquisitions including Medified and The Sandbox.Yahooieso Sharpens Focus on AI-Powered Mental Healthcare with Sale of UK Telecare Services Businessieso sold its UK telecare services business to Mindler, covering NHS-facing care operations including typed and video therapy. The parent company remains independent and will focus on scaling its Velora AI platform for mental health support. ieso's immediate focus is the US market.Business Wire BlogLandmark Study Proves AI-Driven Mental Health Program is as Effective as Human CareA study by ieso Digital Health with the U.K. NHS found its AI-driven anxiety program reduced symptoms in 82% of 300 volunteers, requiring up to eight times fewer therapist hours. The program, benchmarked against NHS data, showed sustained benefits and is being piloted with U.S. payers.PR Newswireieso Digital Health Appoints Dave Icke as Executive Chairieso Digital Health appointed David (Dave) Icke as Executive Chair to lead day-to-day management and the Board of Directors. Icke brings over 30 years of experience in technology and healthcare leadership, including previous roles at Humana, Becton Dickinson, and mc10. The company aims to expand its AI-driven mental health solutions in the US while currently serving over 20 million adults through the UK National Health Service.PR Newswireieso Digital Health Appoints Dave Icke as Executive ChairDave Icke joined ieso Digital Health as Executive Chair, leading day-to-day management and chairing the board. He previously held digital health leadership roles at Humana, Becton Dickinson, and mc10. He plans to expand ieso's reach in the US.BhbusinessData Collection Capabilities Give Providers Insights into Clinician Performance, Patient TreatmentPanelists at The Future of Mental Health event discussed how digital tools can track clinician performance and patient outcomes in behavioral health. ieso and NOCD were cited as examples, with data used to identify underperforming providers and inform care decisions. Concerns about privacy and performative pressure were also raised.ZapierBrookfield to enter 161MW/644MWh battery project in Ontario IESO tenderEvolugen, a Brookfield Renewable subsidiary, proposed a 161MW/644MWh battery storage project near Sault Ste Marie, Ontario, to compete in an IESO tender. The CA$300 million project would co-locate with an existing wind plant and aim to address a projected 4,000-6,000MW capacity shortfall by 2030.